Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adicet Bio Inc (NQ: ACET )

2.035 -0.065 (-3.10%)
Streaming Delayed Price Updated: 9:33 AM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Adicet Bio Inc

< Previous 1 2 3 4 5 6 Next >
Harnessing The Power Of Gamma-Delta T Cells In Cancer Therapy: IN8bio's Innovative Approach
Why Are Gamma-Delta T Cells Important In Fighting Cancer? 
Via Benzinga
Wedbush Maintains Outperform Rating for Adicet Bio: Here's What You Need To Know
Via Benzinga
Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio to Present at the 2023 Jefferies London Healthcare Conference
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Announces Poster Presentation Highlighting ADI-001 Data at the 65th American Society of Hematology (ASH) Annual Meeting
From Adicet Bio, Inc.
Via Business Wire
6 Analysts Have This to Say About Adicet Bio
Via Benzinga
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Announces Poster Presentation at the Upcoming 2023 Molecular Targets and Cancer Therapeutics Conference
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Adicet Reports Second Quarter 2023 Financial Results and Provides Business Updates
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio to Participate in a Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Adicet Announces Appointment of Katie Peng to the Board of Directors
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Analyst Downgrades Adicet Citing Uncertainty, Awaits Long-Term Data On Durability
JMP Securities downgraded Adicet Bio Inc (NASDAQ: ACET) to a Market Perform (from Market Outperform) and removed the  
Via Benzinga
Nasdaq Jumps Over 200 Points; TD Synnex Posts Downbeat Results
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. The Dow traded up 0.73% to 33,959.64 while the NASDAQ rose 1.75% to 13,569.42.... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health. 
Via Benzinga
Dow Up Triple Digits As Consumer Confidence Increases
Stocks are on the rise this afternoon. 
Via Talk Markets
Dow Surges Over 100 Points; Walgreens Lowers Earnings Forecast
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Tuesday. The Dow traded up 0.39% to 33,845.82 while the NASDAQ rose 0.55% to 13,408.91. The S&P 500,... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2023
Via Benzinga
US Stocks Higher; Durable Goods Orders Top Estimates
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 75 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.19% to 33,780.40 while the NASDAQ rose... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why American Equity Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Adicet Bio Stock Is Falling Premarket - Here's Why
Adicet Bio Inc (NASDAQ: ACET) shared safety and efficacy data from its Phase 1 study of ADI-001 for relapsed or refractory aggressive B-cell  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on Tuesday morning! 
Via InvestorPlace
MoonLake Immunotherapeutics, Applied Digital And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)
From Adicet Bio, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.